See all articles

DSM, Evonik to build $200 million omega-3 plant in Nebraska

The facility is expected to come on stream in 2019.

Nutrition companies Evonik and Royal DSM will build a $200 million (€179.4 million) commercial-scale production facility in Blair, Nebraska, to produce omega-3 fatty acids from natural marine algae for animal nutrition.

DSM Nutritional Products and Evonik Nutrition & Care plan to invest $100 million (€89.7 million) each in the facility over the next two years. The initial annual production capacity will meet roughly 15 percent of the current total annual demand for EPA and DHA by the salmon aquaculture industry. 

The facility is expected to come online in 2019. 

Cargill: Sales of salmon feed using antibiotics show sharp decline

Read more

The establishment of the joint venture -- which will be named Veramaris and headquartered in The Netherlands -- will be finalized subject to regulatory approvals.

Evonik has been operating a facility in Blair, Nebraska for almost 20 years and  built a consistent reputation in the local community as an investor and employer.

The new plant will be located adjacent to Evonik’s current facility on Cargill’s site, with established access to the raw materials needed to produce the high value and pure EPA+DHA omega-3 fatty acid oil.

Both companies announced in March 2017 the start of a joint venture, which will allow for the production of omega-3 fatty acids for animal nutrition without using any fish oil from wild caught fish.

Initial applications will be in salmon aquaculture and pet food.

Until the facility in Blair opens, DSM and Evonik will produce pilot-scale quantities of the algal oil at DSM’s production facility in Kingstree, South Carolina.


For more seafood news and updates, follow us on Facebook and Twitter or sign up for our daily newsletter.